South Sudan mounts a nationwide polio vaccination campaign: a massive push towards stopping the ongoing outbreak

Juba, 11 November 2024: A nationwide campaign aimed at vaccinating 3.3 million children from 0 to 59 months of age against polio launched in South Sudan using the novel Oral Polio Vaccine type 2. 

The campaign led by the Ministry of Health, with the support of the World Health Organization (WHO), UNICEF, and other partners, is in response to the confirmation of 12 cases of circulating variant poliovirus across eight counties in Western Equatoria, Central Equatoria, Upper Nile, and Jonglei States. 

In South Sudan, immunization coverage has been impacted by population movements and displacement related to the ongoing humanitarian crisis, making it harder to reach the children who need vaccinations the most. 

The circulating variant poliovirus cases can occur when the weakened live virus in the oral polio vaccine spreads among people who are not fully immunized. This form of the virus can cause paralysis. Multiple doses of the vaccine will protect against both wild and the circulating Vaccine Derived Polio Viruses.

“The resurgence of vaccine-derived poliomyelitis was a shock and a huge setback to our milestone achievement and joy brought about following the declaration of the country wild polio-free in 2020,” said Honourable Yolanda Awel Deng, Minister of Health. “As a country, we are leaving no stone unturned in our resolution to stop the transmission of poliomyelitis. Today, we are mounting this campaign with the aim of ensuring that every child everywhere in South Sudan is not only reached with these vaccines but protected against the disease.”  

“The World Health Organization expresses profound gratitude to the government and people of South Sudan, the generous support from the Global Polio Eradication Initiative (GPEI) partnership, as well as health partners for their unwavering support and dedication to protecting children from polio,” said Dr Humphrey Karamagi, WHO Representative for South Sudan. “This vaccination campaign is an important step in our mission to ensure polio, a disease that can be completely prevented, doesn’t threaten any child’s life. This effort shows our strong commitment to ensuring that no child is at risk of polio.”

“Every child has the right to grow up free from preventable diseases, and polio is one of the most dangerous yet entirely avoidable illnesses. UNICEF reiterates its commitment to support the Ministry of Health and partners in delivering vaccines to every part of South Sudan so that no child is left vulnerable to polio,” said Hamida Lasseko, UNICEF Representative in South Sudan. 

In December 2023, South Sudan confirmed an outbreak of circulating Vaccine Derived Polio Virus Type 2 (cVDPV2) and declared it a ‘Public Health Emergency’. To combat the resurgence of poliomyelitis in the country, two nationwide polio vaccination rounds were successfully conducted in February and April 2024, vaccinating 3.3 million children aged 0 to 59 months during each of the two rounds.

About the circulating Vaccine Derived Polio Virus type 2 (cVDPV2)

Circulating variant poliovirus cases can occur when the weakened live virus in the Oral Polio Vaccine (OPV) regains strength and spreads among people who are not fully immunized. This form of the virus can cause paralysis. To prevent this, all children must get the oral polio vaccine during the campaign, and during the non-campaign time, it is routinely given with other vaccines in the health facility. Getting multiple doses of the vaccine will protect against both wild and circulating variant polioviruses.

Currently, paralytic polio infections are being reported in multiple African countries, including Angola, Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Côte d’Ivoire, the Democratic Republic of the Congo, Ethiopia, Guinea, Ghana, Mali, Niger, Nigeria, Togo, Zambia and South Sudan.

For more information, please contact:
Ministry of Health: George Awzenio Legge, Email: georglolegge [at] gmail.com (georglolegge[at]gmail[dot]com), Tel.: +211924324875
World Health Organization: Atem John, Email: atema [at] who.int (atema[at]who[dot]int), Tel.: +211921736375
UNICEF: Richard Ruati, Email: rruati [at] unicef.org (rruati[at]unicef[dot]org), Tel: 211 921 359 578

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Die Eltern streiten. Dazwischen: das Kind. – Es gibt mehr Fälle von Misshandlung, was auch mit der Pandemie zu tun hat thumbnail

Die Eltern streiten. Dazwischen: das Kind. – Es gibt mehr Fälle von Misshandlung, was auch mit der Pandemie zu tun hat

Vor allem psychische Gewalt hat zugenommen. Das zeigen Zahlen des Zürcher Kinderspitals. «Die Wunden sind nicht sichtbar, aber tief»: Psychische Misshandlung von Kindern ist schweizweit ein Problem. Karin Hofer / NZZ Adrian (Name geändert) sucht Hilfe. Seine Eltern sind getrennt, das Sorgerecht ist eigentlich klar geregelt, aber Konflikte gibt es weiterhin. Ein Elternteil hat ein…
Read More
Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer thumbnail

Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer

Oncology/Hematology > Breast Cancer — Time for "long goodbye" to the "burning red devil," say editorialists by Charles Bankhead, Senior Editor, MedPage Today November 19, 2024 Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease-free survival (DFS) but not overall survival (OS) at 10 years, and doubled the risk of
Read More
FDA OKs First Flu Vaccine for At-Home Use thumbnail

FDA OKs First Flu Vaccine for At-Home Use

Infectious Disease > Flu & URI — FluMist nasal spray can now be used without the help of a healthcare provider by Mike Bassett, Staff Writer, MedPage Today September 20, 2024 The FDA approved FluMist for self- or caregiver-administration, making it the first influenza vaccine that does not need to be administered by a healthcare
Read More
AI ‘Simulants’ Could Save Time and Money on New Medications thumbnail

AI ‘Simulants’ Could Save Time and Money on New Medications

Please enable cookies. Error 1005 Ray ID: 77fa64f43ec7f421 • 2022-12-26 14:09:27 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 77fa64f43ec7f421 • Your IP: 217.21.81.33 •
Read More
COVID Fatigue Pervasive, but Men and Women React Differently thumbnail

COVID Fatigue Pervasive, but Men and Women React Differently

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Most people experience COVID fatigue a few times a week, but men and women and older and younger people have reacted differently to it, a recent WebMD poll suggests. The poll, taken from December 23-January 4, asked readers how often they…
Read More
Index Of News
Total
0
Share